Bull Platinum 30000 Capsules — Class I drug recall D-0654-2020
Terminated recall by Motto International Corp, reported 2020-01-22, distributed in TX. Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
| Recall number | D-0654-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Motto International Corp, Dallas, TX, United States |
| Recall initiated | 2019-12-17 |
| Classified | 2020-01-10 |
| Reported by FDA | 2020-01-22 |
| Terminated | 2021-10-29 |
| Distributed | TX |
| Quantity | 8 boxes |
| Reason classes | unapproved product |
Product
Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX
Reason for recall
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0654-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.